secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001213900-24-053359
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics board amends bylaws to clarify shareholder voting entitlement
-------------------------------------------------------------------------------

- Board approved Amendment No. 2 to Amended and Restated Bylaws on June 14, 2024.
- Amendment restates Article II, Section 2.7(b) regarding shareholders entitled to vote at meetings.
- Effective immediately; no impact on financials or operations disclosed.
- Exhibit 3.1 filed but not appended; details limited to procedural clarification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024053359/0001213900-24-053359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024053359/ea0207966-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-053359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer